시장보고서

상품코드

1629317

위체류 약물전달 시스템 아웃소싱 시장 : 약제 종류별, 제형별, 서비스 종류별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Gastroretentive Drug Delivery Systems Outsourcing Market, By Drug Type, By Dosage Form, By Service Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

위체류 약물전달 시스템 아웃소싱의 시장 규모는 2023년에 14억 9,054만 달러에 달할 것이며, 2024년부터 2032년까지 연평균 7.20%의 CAGR로 확대될 것으로 예상됩니다.

위체류 약물전달 시스템 아웃소싱의 시장 역학

만성질환의 확산으로 위내 체류형 약물전달 시스템 아웃소싱에 대한 수요 증가 전망

세계보건기구(WHO)에 따르면, 당뇨병, 고혈압과 같은 만성질환의 부담이 증가하면서 전 세계 15억 명 이상이 영향을 받고 있어, 위내 체류성 시스템과 같은 혁신적인 약물전달 솔루션에 대한 수요가 증가하고 있습니다. 이러한 시스템은 약물을 장시간 방출하여 치료 효과와 환자 순응도를 향상시킵니다. 제약사들은 운영 비용을 절감하고 복잡한 규제 요건을 충족하기 위해 이러한 시스템의 개발 및 제조를 아웃소싱하는 사례가 증가하고 있습니다. 예를 들어, 미국 FDA는 약물 효능을 향상시키기 위한 방출 제어 기술의 중요성을 강조하며 제조업체의 기술 혁신을 촉구하고 있습니다. 또한, 아웃소싱을 통해 부유성 약물이나 생체접착성 약물 기술에 대한 전문 지식을 활용할 수 있습니다. 인도나 브라질과 같이 의료 인프라가 확대되고 있는 신흥국에서는 비용 효율적인 아웃소싱 솔루션의 기회가 있으며, 기업들은 표적 약물전달 시스템에 대한 수요 증가에 효율적으로 대응할 수 있습니다.

위체류 약물전달 시스템 아웃소싱 시장 : 주요 인사이트

당사의 연구 분석가들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 7.20%의 CAGR로 매년 성장할 것으로 예상됩니다.

약물 유형별로는 항생제가 2023년 가장 큰 시장 점유율을 보일 것으로 예측되었습니다.

제형별로는 정제가 2023년 주요 부문입니다.

서비스 유형별로는 제제 개발이 2023년 주요 부문으로 꼽혔습니다.

지역별로는 북미가 2023년 주요 수익원이었습니다.

위내 체류형 약물전달 시스템 아웃소싱 시장 : 세분화 분석

세계 위체류 약물전달 시스템 아웃소싱 시장은 약물 유형, 제형, 서비스 유형, 최종사용자, 지역에 따라 세분화됩니다.

시장은 약물의 종류에 따라 항당뇨병제, 항생제, 양성자 펌프 억제제, 구토제 등 4가지 범주로 나뉩니다. 항생제는 감염성 질환의 치료에 널리 사용되어 압도적인 점유율을 차지하고 있으며, 그 다음으로 양성자 펌프 억제제가 소화기 질환의 관리에 사용되고 있습니다. 그 다음으로는 당뇨병 치료제가 당뇨병 환자 증가에 힘입어 높은 순위를 차지했으며, 구토제거제는 메스꺼움 관리라는 틈새 시장으로 인해 가장 낮은 우선순위를 차지했습니다.

시장은 제형에 따라 정제, 캡슐, 현탁액, 분말의 네 가지 범주로 나뉩니다. 정제는 제형의 용이성과 환자의 순응도로 인해 가장 높은 우선순위를 차지하고 있으며, 그 다음이 방출 조절 특성을 가진 캡슐제입니다. 그 다음으로 소아 및 노인용 현탁액이 우선순위가 높으며, 분말은 우선순위가 낮으며 주로 특수한 경우에 사용됩니다.

위체류 약물전달 시스템의 아웃소싱 시장 : 지역별 분석

위내 체류형 약물전달 시스템 아웃소싱 시장은 의료 인프라와 제약 혁신의 영향을 받아 뚜렷한 지리적 추세를 보이고 있습니다. 북미는 높은 수준의 의약품 개발 역량, 확립된 제약 산업, FDA의 지원적인 규제 프레임워크로 인해 시장을 선도하고 있습니다. 유럽은 약물전달 기술에 대한 투자 증가와 만성질환 관리를 필요로 하는 고령화로 인해 근소한 차이로 그 뒤를 잇고 있습니다. 아시아태평양에서는 인도와 중국과 같은 국가들이 비용 효율적인 제조, 숙련된 노동력, 확대되는 의료 부문에 힘입어 유력한 아웃소싱 거점으로 부상하고 있습니다. 예를 들어, 인도의 의약품 수출은 2023년 250억 달러를 넘어설 것으로 예상되며, 그 중요성이 점점 더 커지고 있습니다. 라틴아메리카와 중동 및 아프리카는 의료에 대한 접근성이 확대되고 현지 제약 산업을 육성하기 위한 이니셔티브가 있어 완만한 성장세를 보이고 있습니다. 그러나 일부 개발도상국에서는 비용의 제약과 제한된 기술 전문 지식이 보급의 걸림돌로 작용하고 있습니다.

위체류 약물전달 시스템의 아웃소싱 시장 : 경쟁 상황

위내 체류형 약물전달 시스템 아웃소싱 시장은 경쟁이 치열하며, 세계 및 지역 업체들이 기술 혁신, 전략적 파트너십, 규제 기준 준수에 주력하고 있으며, Lonza Group, Catalent Inc, Recipharm AB와 같은 신흥 기업들은 제형 개발 및 제조를 포함한 종합적인 아웃소싱 서비스를 제공함으로써 시장을 독점하고 있습니다. 이들 기업은 연구개발에 많은 투자를 하고 있으며, 부유성, 생체접착성, 팽창성 시스템과 같은 첨단 위내 체류성 기술을 자사 포트폴리오에 통합하고 있습니다. 특히 아시아태평양의 신생 기업들은 비용 효율적인 생산과 특수 약물전달 솔루션에 대한 수요 증가를 활용하고 있습니다. 제약사와의 공동 개발을 통해 맞춤형 시스템을 개발하고 서비스 포트폴리오를 확장하는 것이 일반적인 전략입니다. 예를 들어, 만성질환 관리를 위한 생체접착 시스템 개발에 대한 파트너십이 활발히 진행되고 있습니다. 또한, 지속가능한 제조 방법에 대한 관심이 높아지면서 시장 진입자들 간의 경쟁이 더욱 치열해지고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동·후리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : 위체류 약물전달 시스템 아웃소싱 업계

경쟁 대시보드
- 경쟁 벤치마크
- 경쟁 포지셔닝
기업 개요
- Ajinomoto Bio-Pharma Services
- Alcami Corporation
- Boehringer Ingelheim International GmbH
- Catalent, Inc.
- Charles River Laboratories
- Evonik Industries AG
- Famar SA
- Jubilant Pharmova Limited
- Lonza Group AG
- Patheon NV
- Piramal Pharma Solutions
- Recipharm AB
- Syngene International Limited
- Thermo Fisher Scientific Inc.
- Vetter Pharma International GmbH
- WuXi AppTec Co., Ltd.
- Others

제13장 AnalystView의 전방위적 분석

ksm 25.02.18

REPORT HIGHLIGHT

The Gastroretentive Drug Delivery Systems Outsourcing Market size was valued at USD 1,490.54 million in 2023, expanding at a CAGR of 7.20% from 2024 to 2032.

The Gastroretentive Drug Delivery Systems Outsourcing Market focuses on outsourcing services related to drug delivery systems designed to remain in the stomach for extended periods, ensuring controlled and targeted drug release. The rising prevalence of gastrointestinal disorders and chronic conditions like diabetes and hypertension, which collectively affect over 1.5 billion people globally, has created a significant demand for advanced drug delivery mechanisms. Pharmaceutical companies increasingly rely on outsourcing for cost-efficiency, access to specialized expertise, and adherence to stringent regulatory standards. However, challenges such as high development costs and complexities in maintaining quality compliance restrain market growth. On the other hand, technological advancements, such as floating and bioadhesive drug delivery systems, along with expanding healthcare infrastructure in emerging economies, present lucrative opportunities for service providers to enhance their offerings.

Gastroretentive Drug Delivery Systems Outsourcing Market- Market Dynamics

Expanding Prevalence of Chronic Diseases Boosts Demand for Gastroretentive Drug Delivery Systems Outsourcing

The rising burden of chronic diseases such as diabetes and hypertension, which together impact over 1.5 billion individuals globally according to the WHO, has driven demand for innovative drug delivery solutions like gastroretentive systems. These systems ensure prolonged drug release, improving therapeutic outcomes and patient adherence. Pharmaceutical companies increasingly outsource the development and manufacturing of these systems to reduce operational costs and meet complex regulatory requirements. For instance, the U.S. FDA emphasizes the importance of controlled-release technologies to enhance drug efficacy, pushing manufacturers to innovate. Additionally, outsourcing provides access to specialized expertise in floating and bioadhesive drug technologies. Emerging economies with expanding healthcare infrastructure, like India and Brazil, offer opportunities for cost-effective outsourcing solutions, enabling companies to cater to the growing demand for targeted drug delivery systems efficiently.

Gastroretentive Drug Delivery Systems Outsourcing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.20% over the forecast period (2024-2032)

Based on Drug Type segmentation, Antibiotics was predicted to show maximum market share in the year 2023

Based on Dosage Form segmentation, Tablets was the leading segment in 2023

Based on Service Type segmentation, Formulation Development was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Gastroretentive Drug Delivery Systems Outsourcing Market- Segmentation Analysis:

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is segmented on the basis of Drug Type, Dosage Form, Service Type, End-User, and Region.

The market is divided into four categories based on Drug Type: Antidiabetics, Antibiotics, Proton Pump Inhibitors, and Antiemetics. Antibiotics dominate due to widespread use in treating infections, followed by proton pump inhibitors for managing gastrointestinal conditions. Antidiabetics rank next, driven by rising diabetes prevalence, while antiemetics hold the lowest priority for their niche application in nausea management.

The market is divided into four categories based on Dosage Form: Tablets, Capsules, Suspensions, and Powders. Tablets hold the highest priority due to ease of formulation and patient compliance, followed by capsules for their controlled-release properties. Suspensions rank next, preferred for pediatric and geriatric use, while powders are least prioritized, used primarily in specialized cases.

Gastroretentive Drug Delivery Systems Outsourcing Market- Geographical Insights

The Gastroretentive Drug Delivery Systems Outsourcing Market shows distinct geographical trends influenced by healthcare infrastructure and pharmaceutical innovation. North America leads the market due to advanced drug development capabilities, well-established pharmaceutical industries, and supportive regulatory frameworks by the FDA. Europe follows closely, driven by rising investments in drug delivery technologies and an aging population requiring chronic disease management. In Asia-Pacific, countries like India and China are emerging as prominent outsourcing hubs, fueled by cost-effective manufacturing, skilled labor, and expanding healthcare sectors. For instance, India's pharmaceutical exports crossed $25 billion in 2023, showcasing its growing prominence. Latin America and the Middle East & Africa exhibit moderate growth due to increasing healthcare access and initiatives to promote local pharmaceutical industries. However, cost constraints and limited technical expertise in some developing regions pose challenges to widespread adoption.

Gastroretentive Drug Delivery Systems Outsourcing Market- Competitive Landscape:

The Gastroretentive Drug Delivery Systems Outsourcing Market is highly competitive, with global and regional players focusing on technological innovation, strategic partnerships, and compliance with regulatory standards. Leading companies like Lonza Group, Catalent Inc., and Recipharm AB dominate the market by offering comprehensive outsourcing services, including formulation development and manufacturing. These players invest heavily in R&D to integrate advanced gastroretentive technologies, such as floating, bioadhesive, and swelling systems, into their portfolios. Emerging firms, particularly in Asia-Pacific, capitalize on cost-effective production and growing demand for specialized drug delivery solutions. Collaborations with pharmaceutical companies to develop tailored systems and expand service portfolios are common strategies. For instance, partnerships in the development of bioadhesive systems for chronic disease management have gained momentum. Additionally, increasing interest in sustainable manufacturing practices further intensifies competition among market participants.

Recent Developments:

In August 2022, Catalent announced its acquisition of Metrics Contract Services for USD 475 million to enhance its oral development and manufacturing capabilities. This acquisition aims to strengthen Catalent's expertise in integrated oral solid formulation, research, production, and packaging.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Ajinomoto Bio-Pharma Services
Alcami Corporation
Boehringer Ingelheim International GmbH
Catalent, Inc.
Charles River Laboratories
Evonik Industries AG
Famar SA
Jubilant Pharmova Limited
Lonza Group AG
Patheon N.V.
Piramal Pharma Solutions
Recipharm AB
Syngene International Limited
Thermo Fisher Scientific Inc.
Vetter Pharma International GmbH
WuXi AppTec Co., Ltd.
Others

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032

Antidiabetics
Antibiotics
Proton Pump Inhibitors
Antiemetics

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

Tablets
Capsules
Suspensions
Powders

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Formulation Development
Analytical Testing
Clinical Trials Management
Drug Manufacturing

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Pharmaceutical Companies
Biotech Companies
CROs
CMO

GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS OUTSOURCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Gastroretentive Drug Delivery Systems Outsourcing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Drug Type
- 2.1.2. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Dosage Form
- 2.1.3. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Service Type
- 2.1.4. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by End-User
- 2.1.5. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Country
- 2.1.6. Gastroretentive Drug Delivery Systems Outsourcing Market Snippet by Region
2.2. Competitive Insights

3. Gastroretentive Drug Delivery Systems Outsourcing Key Market Trends

3.1. Gastroretentive Drug Delivery Systems Outsourcing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Gastroretentive Drug Delivery Systems Outsourcing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Gastroretentive Drug Delivery Systems Outsourcing Market Opportunities
3.4. Gastroretentive Drug Delivery Systems Outsourcing Market Future Trends

4. Gastroretentive Drug Delivery Systems Outsourcing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Gastroretentive Drug Delivery Systems Outsourcing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Gastroretentive Drug Delivery Systems Outsourcing Market Landscape

6.1. Gastroretentive Drug Delivery Systems Outsourcing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Gastroretentive Drug Delivery Systems Outsourcing Market - By Drug Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
- 7.1.2. Antidiabetics
- 7.1.3. Antibiotics
- 7.1.4. Proton Pump Inhibitors
- 7.1.5. Antiemetics

8. Gastroretentive Drug Delivery Systems Outsourcing Market - By Dosage Form

8.1. Overview
- 8.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
- 8.1.2. Tablets
- 8.1.3. Capsules
- 8.1.4. Suspensions
- 8.1.5. Powders

9. Gastroretentive Drug Delivery Systems Outsourcing Market - By Service Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 9.1.2. Formulation Development
- 9.1.3. Analytical Testing
- 9.1.4. Clinical Trials Management
- 9.1.5. Drug Manufacturing

10. Gastroretentive Drug Delivery Systems Outsourcing Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Pharmaceutical Companies
- 10.1.3. Biotech Companies
- 10.1.4. CROs
- 10.1.5. CMOs

11. Gastroretentive Drug Delivery Systems Outsourcing Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Gastroretentive Drug Delivery Systems Outsourcing Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Gastroretentive Drug Delivery Systems Outsourcing Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Ajinomoto Bio-Pharma Services
- 12.2.2. Alcami Corporation
- 12.2.3. Boehringer Ingelheim International GmbH
- 12.2.4. Catalent, Inc.
- 12.2.5. Charles River Laboratories
- 12.2.6. Evonik Industries AG
- 12.2.7. Famar SA
- 12.2.8. Jubilant Pharmova Limited
- 12.2.9. Lonza Group AG
- 12.2.10. Patheon N.V.
- 12.2.11. Piramal Pharma Solutions
- 12.2.12. Recipharm AB
- 12.2.13. Syngene International Limited
- 12.2.14. Thermo Fisher Scientific Inc.
- 12.2.15. Vetter Pharma International GmbH
- 12.2.16. WuXi AppTec Co., Ltd.
- 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us